News

The FDA has approved midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukemia.

A recent study has found correlations between common comorbidities (hypertension, heart disease, diabetes, etc) and ovarian cancer.

The FDA has approved regorafenib as a second-line treatment for patients with unresectable hepatocellular carcinoma, who had previously received sorafenib.

A recent study evaluated the effect of red light on hair growth in women with breast cancer.

Second primary cancers that occur in pediatric, adolescent and young adult (AYA) patients are deadlier than those that occur in older patients.

The FDA issued 14 warning letters and 4 online adviseries to a number of companies selling products which claim to prevent, diagnose, treat, mitigate or cure cancer without FDA approval.

While patients with stage III or IV melanoma who received a higher dose of ipilimumab did live longer than those on a lower dose, there was also greater toxicity.

For patients with hepatocellular carcinoma (HCC) who have progressed on sorafenib, regorafenib has shown to be an effective second-line treatment. The FDA has granted the agent a priority review

Steve Pake, a testicular cancer survivors gives some insight as April is testicular cancer awareness month.

For patients receiving oral chemotherapy, satisfaction with communication may enhance adherence.

For BRCA1/2 and other genes, it is important that practitioners begin testing for heriditary genes for ovarian cancers.

The UK Myeloma Forum and the British Society for Haematology collaborated to create a comprehensive, multidisciplinary guideline document for the screening, management, and long-term care of patients with myeloma.

The Paxman Scalp Cooling System has been granted FDA clearance to reduce hait loss in patients with breast cancer recieving chemotherapy.

New modalities of treatments for patients with Ewing sarcoma have expanded overall survival. However, there are few studies done on the long-term quality of life issues these patients may experience.

Several patient-related risk factors for chemotherapy-induced nausea and vomiting (CINV) have been identified and compiled into a CINV prediction tool.

With more patients diagnosed with breast cancer looking to contralateral prophylactic mastectomy, it is important that surgeons discuss this procedure in-depth so patients can better understand.

The Food and Drug Administration (FDA) granted an accelerated approval to atezolizumab (Tecentriq) to be used as a frontline treatment for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma (mUC).

The FDA has eliminated the need for REMS certification before administration of ESAs for anemia due to myelosuppressive chemotherapy.

Amanda Bontempo, MS, RD, CSO, CDN, gives some tips for healthy eating. Join us on 4/18 at 1 PM for our tweetchat, with Bontempo as moderator, to discuss more nutrition.

Thought the incidence of breast cancer has decreased in many US racial/ethnic populations, the rate has increased in the Asian-American population.

After losing her husband to stage III esophageal cancer, Mindy Mordecai came together with top physicians, business leaders and families affected by the disease to found Esophageal Cancer Action Network (ECAN).

There may be a shift away from the USPSTF's opposition to routine PSA screening for prostate cancer in some men.

A recent study determined that an education initiative could help to ease worries patients with cancer may have about palliative care, thus improving quality of life.

As prevalence of HPV within the population rises, incidence of HPV-related cancers is expected to rise.

For adolescent and young adult patients with cancer, navigating social life after their diagnosis can be difficult.

A recent review has found substantial evidence linking androgen deprivation therapy (ADT) to dementia in patients with prostate cancer.

Tricia Strusowski, MS, RN, discusses the importance of a nurse navigator to both the patient and the center.

With antiretroviral drugs easing the burden of AIDS-defining cancers in HIV-positive patients, the most common cancers in this population are expected to shift to those associated with aging.

A new policy statement from ASCO addresses the specific needs in oncology of patients in the sexual and gender minority populations.

A recent meta-analysis found that the most effective treatments for cancer-related fatigue are exercise and psychological interventions.